“Pharmacological inhibition of p38 MAPK significantly reduced α-SMA and Col3A1 expression in both TGF-β1-stimulated fibroblasts and primary IPF cells” Led by Shan Zhu — with corresponding author Yan Y ...
GSK-3179106 reduces inflammation and acute lung injury in mice through p38 MAPK targeting Nov. 29, 2024 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results